Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 7
1975 6
1976 3
1977 7
1978 5
1979 8
1980 12
1981 12
1982 21
1983 23
1984 11
1985 27
1986 21
1987 31
1988 26
1989 39
1990 43
1991 46
1992 55
1993 65
1994 51
1995 78
1996 89
1997 85
1998 134
1999 99
2000 86
2001 97
2002 93
2003 106
2004 86
2005 93
2006 83
2007 101
2008 84
2009 68
2010 72
2011 93
2012 96
2013 102
2014 100
2015 113
2016 92
2017 80
2018 70
2019 80
2020 88
2021 98
2022 109
2023 97
2024 105
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,119 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Ten-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy.
Qian HS, Li WJ, Dang YN, Li LR, Xu XB, Yuan L, Zhang WF, Yang Z, Gao X, Zhang M, Li X, Zhang GX. Qian HS, et al. Am J Gastroenterol. 2023 Apr 1;118(4):627-634. doi: 10.14309/ajg.0000000000002086. Epub 2022 Dec 2. Am J Gastroenterol. 2023. PMID: 36729890 Clinical Trial.
INTRODUCTION: No study has investigated the efficacy and safety of vonoprazan-amoxicillin dual therapy compared with bismuth quadruple therapy (B-quadruple). This study aimed to evaluate the efficacy and safety of 10-day vonoprazan-amoxicillin dual therapy as a firs …
INTRODUCTION: No study has investigated the efficacy and safety of vonoprazan-amoxicillin dual therapy compared with bismuth quadrupl …
Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.
R Marques I, P Calvi I, A Cruz S, M F Sanchez L, F Baroni I, Oommen C, H Padrao EM, C Mari P. R Marques I, et al. Eur J Pediatr. 2022 Nov;181(11):3795-3804. doi: 10.1007/s00431-022-04603-8. Epub 2022 Sep 6. Eur J Pediatr. 2022. PMID: 36066660 Review.
The World Health Organization (WHO) recommends a 5-day Amoxicillin-based empiric treatment. However, longer treatments are frequently used. This study aimed to compare shorter and longer Amoxicillin regimens for children with uncomplicated community-acquired pneumon …
The World Health Organization (WHO) recommends a 5-day Amoxicillin-based empiric treatment. However, longer treatments are frequently …
Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
Ouyang Y, Wang M, Xu YL, Zhu Y, Lu NH, Hu Y. Ouyang Y, et al. J Gastroenterol Hepatol. 2022 Sep;37(9):1666-1672. doi: 10.1111/jgh.15917. Epub 2022 Jun 27. J Gastroenterol Hepatol. 2022. PMID: 35716370
BACKGROUND AND AIM: The efficacy and safety of amoxicillin-vonoprazan (VA) dual therapy remained unclear. METHODS: This systematic review was conducted in accordance with the PRISMA 2009 guidelines. ...No significant differences were observed regarding the VA dual therapy …
BACKGROUND AND AIM: The efficacy and safety of amoxicillin-vonoprazan (VA) dual therapy remained unclear. METHODS: This systematic re …
Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
Llor C, Pérez A, Carandell E, García-Sangenís A, Rezola J, Llorente M, Gestoso S, Bobé F, Román-Rodríguez M, Cots JM, Hernández S, Cortés J, Miravitlles M, Morros R. Llor C, et al. Aten Primaria. 2019 Jan;51(1):32-39. doi: 10.1016/j.aprim.2017.08.003. Epub 2017 Oct 20. Aten Primaria. 2019. PMID: 29061311 Free PMC article. Clinical Trial.
EudraCT register 2012-003511-63. RESULTS: A total of 43 subjects (amoxicillin: 28; penicillin: 15) were randomized. Clinical cure was observed in 10 (90.9%) patients assigned to penicillin and in 25 (100%) patients assigned to amoxicillin with a difference of -9.1% …
EudraCT register 2012-003511-63. RESULTS: A total of 43 subjects (amoxicillin: 28; penicillin: 15) were randomized. Clinical cure was …
Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
Zhou BG, Jiang X, Ding YB, She Q, Li YY. Zhou BG, et al. Helicobacter. 2024 Jan-Feb;29(1):e13040. doi: 10.1111/hel.13040. Epub 2023 Nov 20. Helicobacter. 2024. PMID: 37983865 Review.
BACKGROUND AND OBJECTIVE: Recently, vonoprazan-amoxicillin (VA) dual therapy has been reported as a promising approach for Helicobacter pylori (H. pylori) eradication. ...
BACKGROUND AND OBJECTIVE: Recently, vonoprazan-amoxicillin (VA) dual therapy has been reported as a promising approach for Helicobact …
Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis of randomized controlled trials.
Zhou BG, Mei YZ, Jiang X, Zheng AJ, Ding YB. Zhou BG, et al. Saudi J Gastroenterol. 2023 Nov-Dec;29(6):347-357. doi: 10.4103/sjg.sjg_153_23. Saudi J Gastroenterol. 2023. PMID: 37602635 Free PMC article.
BACKGROUND: Vonoprazan-amoxicillin (VA) dual therapy has recently been proposed to eradicate Helicobacter pylori (H. pylori) with controversial results. ...Future RCTs are needed to ascertain the optimal dosage and duration of vonoprazan and amoxicillin, and the eff …
BACKGROUND: Vonoprazan-amoxicillin (VA) dual therapy has recently been proposed to eradicate Helicobacter pylori (H. pylori) with con …
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis.
Gao CP, Zhang D, Zhang T, Wang JX, Han SX, Graham DY, Lu H. Gao CP, et al. Helicobacter. 2020 Aug;25(4):e12692. doi: 10.1111/hel.12692. Epub 2020 Apr 20. Helicobacter. 2020. PMID: 32314468
We aimed to investigate whether PPI-amoxicillin dual therapy is effective. METHODS: We searched several publication databases for randomized controlled trials (RCTs) that compared PPI-amoxicillin dual therapy with controls up to March 2019. ...CONCLUSIONS: Compared …
We aimed to investigate whether PPI-amoxicillin dual therapy is effective. METHODS: We searched several publication databases for ran …
Does the use of amoxicillin/amoxicillin-clavulanic acid in third molar surgery reduce the risk of postoperative infection? A systematic review with meta-analysis.
Menon RK, Gopinath D, Li KY, Leung YY, Botelho MG. Menon RK, et al. Int J Oral Maxillofac Surg. 2019 Feb;48(2):263-273. doi: 10.1016/j.ijom.2018.08.002. Epub 2018 Aug 23. Int J Oral Maxillofac Surg. 2019. PMID: 30145064
The objectives of this systematic review were to investigate the efficacy of amoxicillin/amoxicillin-clavulanic acid for reducing the risk of postoperative infection after third molar surgery and to evaluate the adverse outcomes in these patients, as well as in heal …
The objectives of this systematic review were to investigate the efficacy of amoxicillin/amoxicillin-clavulanic acid for reduc …
PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis.
Li C, Shi Y, Suo B, Tian X, Zhou L, Song Z. Li C, et al. Helicobacter. 2021 Aug;26(4):e12816. doi: 10.1111/hel.12816. Epub 2021 May 17. Helicobacter. 2021. PMID: 34002433
BACKGROUND: Systematic reviews suggested that the eradication efficacy of PPI-amoxicillin dual therapy is similar to that of other commonly used regimens. However, it might be affected by the medication frequency. ...The safety of dual therapy was significantly better than …
BACKGROUND: Systematic reviews suggested that the eradication efficacy of PPI-amoxicillin dual therapy is similar to that of other co …
The efficacy and safety of vonoprazan-amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis.
Feng JH, Cheng J, Lao YJ, Huang K, Mou JL, Hu F, Lin ML, Lin J. Feng JH, et al. Eur J Med Res. 2023 Aug 7;28(1):272. doi: 10.1186/s40001-023-01249-6. Eur J Med Res. 2023. PMID: 37550781 Free PMC article. Review.
AIM: To evaluate the efficacy and safety of vonoprazan-amoxicillin (VA) dual therapy for radically eradicating Helicobacter pylori (H. pylori). ...
AIM: To evaluate the efficacy and safety of vonoprazan-amoxicillin (VA) dual therapy for radically eradicating Helicobacter pylori (H …
3,119 results